Rocket Pharmaceuticals, Inc.
RCKT· Nasdaq
Released Nov 3, 2022, after the close
10-Q filed Nov 4, 2022, 35 days after period end · 0001140361-22-040004
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$57.76M | -$50.12M | -$29.08M | -$19.28M |
| EPS Diluted |
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR
| -$0.87 |
| -$0.79 |
| -$0.53 |
| -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.